Actylis combines Aceto and its 10 acquired specialists into a singular global brand.
Actylis, a global manufacturer and sourcing expert of raw materials and performance ingredients, announced its debut on Sept. 26, 2022. The new company combines Aceto and 10 industry specialists into an integrated global ingredient powerhouse; A&C, A&C Bio Buffer, Biotron Laboratories, Cascade Chemistry, Finar, Inter-Actifs, IsleChem, Pharma Waldhof, Syntor Fine Chemicals, and Talus.
According to a company press release, Actylis aims to address the major unmet need for better and more dependable access to critical raw materials and performance ingredients needed for the manufacture of highly regulated products in key industries. The combination of the many specialists will enable Actylis’ hybrid manufacturing and sourcing model, which is designed to provide various benefits to its customers in high-growth end markets.
“Actylis unites multiple industry specialists with a wide range of capabilities into a new, global enterprise with a unique hybrid approach that is greater than the sum of its parts,” said Gilles Cottier, CEO of Actylis, in the release. “This consolidation enables us to offer customers across diverse locations and industries highly flexible, customized solutions addressing their specific needs, while assuring reliable on-time delivery of the high-quality ingredients essential to their success.”
Source: Aceto
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.